The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Cooperative Epigenetic Modulation by Cancer Amplicon Genes
Open accessAbstract
Chromosome band 9p24 is frequently amplified in primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL). To identify oncogenes in this amplicon, we screened an RNA interference library targeting amplicon genes and thereby identified JAK2 and the histone demethylase JMJD2C as essential genes in these lymphomas. Inhibition of JAK2 and JMJD2C cooperated in killing these lymphomas by decreasing tyrosine 41 phosphorylation and increasing lysine 9 trimethylation of histone H3, promoting heterochromatin formation. MYC, a major target of JAK2-mediated histone phosphorylation, was silenced following JAK2 and JMJD2C inhibition, with a corresponding increase in repressive chromatin. Hence, JAK2 and JMJD2C cooperatively remodel the PMBL and HL epigenome, offering a mechanistic rationale for the development of JAK2 and JMJD2C inhibitors in these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868 · cited 2×
“HP1a uses its chromo domain to bind histone H3K9me3 (Bannister et al., 2001; Lachner et al., 2001), and demethylation of this residue by JMJD2C removes this HP1a binding site (Cloos et al., 2006; Loh et al., 2007;Whetstine et al., 2006; Wissmann et al., 2007).”
BackgroundOncogenic pathway signatures in human cancers as a guide to targeted therapies
Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M.-B., Harpole, D., Lancaster, J. M., Berchuck, A., et al. (2006) · Nature · doi:10.1038/nature04296 · Cited by 2,032
Janus kinases in immune cell signaling
Ghoreschi, K., Laurence, A., & O’Shea, J. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00754.x · Cited by 1,149 · cited 2×
“JAK kinases phosphorylate STAT transcription factors, causing their relocation to the nucleus where they activate target genes bearing STAT binding motifs (Ghoreschi et al., 2009).”
BackgroundRosenwald, A., Wright, G., Leroy, K., Yu, X., Gaulard, P., Gascoyne, R. D., Chan, W. C., Zhao, T., Haioun, C., Greiner, T. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031074 · Cited by 1,101
Self-citationReversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases
Whetstine, J. R., Nottke, A., Lan, F., Huarte, M., Smolikov, S., Chen, Z., Spooner, E., Li, E., Zhang, G., Colaiacovo, M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.028 · Cited by 1,040
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Lenz, G., Wright, G. W., Emre, N. C. T., Kohlhammer, H., Dave, S. S., Davis, R. E., Carty, S., Lam, L. T., Shaffer, A. L., Xiao, W., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804295105 · Cited by 995
Self-citationRb targets histone H3 methylation and HP1 to promoters
Nielsen, S. J., Schneider, R., Bauer, U.-M., Bannister, A. J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R. E., et al. (2001) · Nature · doi:10.1038/35087620 · Cited by 904
Savage, K. J. (2003) · Blood · doi:10.1182/blood-2003-06-1841 · Cited by 855
Self-citationDiehl, V., Franklin, J., Pfreundschuh, M., Lathan, B., Paulus, U., Hasenclever, D., Tesch, H., Herrmann, R., Dörken, B., Müller-Hermelink, H.-K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022473 · Cited by 838
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3
Cloos, P. A. C., Christensen, J., Agger, K., Maiolica, A., Rappsilber, J., Antal, T., Hansen, K. H., & Helin, K. (2006) · Nature · doi:10.1038/nature04837 · Cited by 736
IRF4 addiction in multiple myeloma
Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature · doi:10.1038/nature07064 · Cited by 730
Self-citationJAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
Dawson, M. A., Bannister, A. J., Göttgens, B., Foster, S. D., Bartke, T., Green, A. R., & Kouzarides, T. (2009) · Nature · doi:10.1038/nature08448 · Cited by 622
Facultative Heterochromatin: Is There a Distinctive Molecular Signature?
Trojer, P., & Reinberg, D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.011 · Cited by 608
A loss-of-function RNA interference screen for molecular targets in cancer
Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J., et al. (2006) · Nature · doi:10.1038/nature04687 · Cited by 605
Self-citationCooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression
Wissmann, M., Yin, N., Müller, J. M., Greschik, H., Fodor, B. D., Jenuwein, T., Vogler, C., Schneider, R., Günther, T., Buettner, R., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1546 · Cited by 598
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Hedvat, M., Huszar, D., Herrmann, A., Gozgit, J. M., Schroeder, A., Sheehy, A., Buettner, R., Proia, D., Kowolik, C. M., Xin, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.015 · Cited by 526
Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System
LaPorte, S. L., Juo, Z. S., Vaclavikova, J., Colf, L. A., Qi, X., Heller, N. M., Keegan, A. D., & Garcia, K. C. (2008) · Cell · doi:10.1016/j.cell.2007.12.030 · Cited by 517
Global mapping of c-Myc binding sites and target gene networks in human B cells
Zeller, K. I., Zhao, X., Lee, C. W. H., Chiu, K. P., Yao, F., Yustein, J. T., Ooi, H. S., Orlov, Y. L., Shahab, A., Yong, H. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604129103 · Cited by 516
Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells
Loh, Y.-H., Zhang, W., Chen, X., George, J., & Ng, H.-H. (2007) · Genes & Development · doi:10.1101/gad.1588207 · Cited by 443
Wernig, G., Kharas, M. G., Okabe, R., Moore, S. A., Leeman, D. S., Cullen, D. E., Gozo, M., McDowell, E. P., Levine, R. L., Doukas, J., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.009 · Cited by 390
Weniger, M. A., Melzner, I., Menz, C. K., Wegener, S., Bucur, A. J., Dorsch, K., Mattfeldt, T., Barth, T. F. E., & Möller, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209151 · Cited by 322
Self-citationLam, L. T., Davis, R. E., Pierce, J., Hepperle, M. E., Xu, Y., Foley, M. H., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005) · PubMed · Cited by 312
Self-citationSkinnider, B. F., Elia, A. J., Gascoyne, R. D., Patterson, B., Trumper, L., Kapp, U., & Mak, T. W. (2002) · Blood · doi:10.1182/blood.v99.2.618 · Cited by 288
Self-citationGenomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.
Joos, S., Küpper, M., Ohl, S., von Bonin, F., Mechtersheimer, G., Bentz, M., Marynen, P., Mӧller, P., Pfreundschuh, M. G., Trümper, L. H. P., et al. (2000) · PubMed · Cited by 273
Self-citationEmmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.-D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3129 · Cited by 261
Santos, F. P. S., Kantarjian, H. M., Jain, N., Manshouri, T., Thomas, D. A., Garcia-Manero, G., Kennedy, D., Estrov, Z., Cortes, J., & Verstovsek, S. (2010) · Blood · doi:10.1182/blood-2009-10-246363 · Cited by 233
Lam, L. T., Davis, R. E., Pierce, J., Hepperle, M., Xu, Y., Hottelet, M., Nong, Y., Wen, D., Adams, J., Dang, L., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.28.11.1 · Cited by 229
Self-citationA library of gene expression signatures to illuminate normal and pathological lymphoid biology
Shaffer, A. L., Wright, G., Yang, L., Powell, J., Ngo, V., Lamy, L., Lam, L. T., Davis, R. E., & Staudt, L. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00373.x · Cited by 228
Self-citationYang, Z., Imoto, I., Fukuda, Y., Pimkhaokham, A., Shimada, Y., Imamura, M., Sugano, S., Nakamura, Y., & Inazawa, J. (2000) · PubMed · Cited by 228
Melzner, I., Bucur, A. J., Brüderlein, S., Dorsch, K., Hasel, C., Barth, T. F. E., Leithäuser, F., & Möller, P. (2005) · Blood · doi:10.1182/blood-2004-09-3701 · Cited by 215
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Liu, G., Bollig-Fischer, A., Kreike, B., van de Vijver, M. J., Abrams, J., Ethier, S. P., & Yang, Z. Q. (2009) · Oncogene · doi:10.1038/onc.2009.297 · Cited by 202
Skinnider, B. F. (2001) · Blood · doi:10.1182/blood.v97.1.250 · Cited by 197
Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma
Guiter, C., Dusanter-Fourt, I., Copie-Bergman, C., Boulland, M.-L., le Gouvello, S., Gaulard, P., Leroy, K., & Castellano, F. (2004) · Blood · doi:10.1182/blood-2003-10-3545 · Cited by 197
Verschure, P. J., van der Kraan, I., de Leeuw, W., van der Vlag, J., Carpenter, A. E., Belmont, A. S., & van Driel, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4552-4564.2005 · Cited by 183
JAK signaling globally counteracts heterochromatic gene silencing
Shi, S., Calhoun, H. C., Xia, F., Li, J., Le, L., & Li, W. X. (2006) · Nature Genetics · doi:10.1038/ng1860 · Cited by 177
Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability
Shi, S., Larson, K., Guo, D., Lim, S. J., Dutta, P., Yan, S., & Li, W. X. (2008) · Nature Cell Biology · doi:10.1038/ncb1713 · Cited by 153
Yamamoto, K., & Sonoda, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03021-8 · Cited by 142
Selective Inhibition of JAK2-Driven Erythroid Differentiation of Polycythemia Vera Progenitors
Geron, I., Abrahamsson, A. E., Barroga, C. F., Kavalerchik, E., Gotlib, J. R., Hood, J. D., Durocher, J. A., Mak, C. C., Noronha, G., Söll, R., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.017 · Cited by 138
Ehrbrecht, A., Müller, U., Wolter, M., Hoischen, A., Koch, A., Radlwimmer, B., Actor, B., Mincheva, A., Pietsch, T., Lichter, P., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1925 · Cited by 135
Vinatzer, U., Gollinger, M., Müllauer, L., Raderer, M., Chott, A., & Streubel, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0702 · Cited by 126
Mottok, A., Renné, C., Seifert, M., Oppermann, E., Bechstein, W., Hansmann, M.-L., Küppers, R., & Bräuninger, A. (2009) · Blood · doi:10.1182/blood-2009-06-225839 · Cited by 124
Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas
Meier, C., Hoeller, S., Bourgau, C., Hirschmann, P., Schwaller, J., Went, P., Pileri, S. A., Reiter, A., Dirnhofer, S., & Tzankov, A. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.207 · Cited by 88
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma
Mader, A., Brüderlein, S., Wegener, S., Melzner, I., Popov, S., Müller‐Hermelink, H. K., Barth, T. F. E., Viardot, A., & Mӧller, P. (2007) · Cytogenetic and Genome Research · doi:10.1159/000112062 · Cited by 51
Self-citationMestre, C., Rubio-Moscardó, F., Rosenwald, A., Climent, J., Dyer, M. J. S., Staudt, L. M., Pinkel, D., Siebert, R., & Martinez-Climent, J. A. (2005) · Leukemia · doi:10.1038/sj.leu.2403741 · Cited by 31
Self-citation
Cited by
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Analysis of the coding genome of diffuse large B-cell lymphoma
Pasqualucci, L., Trifonov, V., Fabbri, G., Ma, J., Rossi, D., Chiarenza, A., Wells, V. A., Grunn, A., Messina, M., Elliot, O., et al. (2011) · Nature Genetics · doi:10.1038/ng.892 · Cited by 971
JAKs and STATs in immunity, immunodeficiency, and cancer
O'Shea, J. J., Holland, S. M., & Staudt, L. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1202117 · Cited by 927
Self-citationInterplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 910
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Chapuy, B., Roemer, M. G. M., Stewart, C., Tan, Y., Abo, R. P., Zhang, L., Dunford, A. J., Meredith, D. M., Thorner, A. R., Jordanova, E. S., et al. (2016) · Blood · doi:10.1182/blood-2015-10-673236 · Cited by 585
Metadata
- Authors
- Rui, L., Emre, N. C. T., Kruhlak, M. J., Chung, H.-J., Steidl, C., Slack, G., Wright, G. W., Lenz, G., Ngo, V. N., Shaffer, A. L., Xu, W., Zhao, H., Yang, Y., Lamy, L., Davis, R. E., Xiao, W., Powell, J., Maloney, D., Thomas, C. J., Möller, P., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Savage, K., Connors, J. M., Rimsza, L. M., Campo, E., Jaffe, E. S., Delabie, J., Smeland, E. B., Weisenburger, D. D., Chan, W. C., Gascoyne, R. D., Levens, D., & Staudt, L. M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 18
- Issue
- 6
- Pages
- 590-605
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2047181533
- Cited by
- 283
- References
- 46
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.